Search Results - "Koay, Tsin Shue"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma by Wu, Chiao-En, Koay, Tsin Shue, Esfandiari, Arman, Ho, Yi-Hsuan, Lovat, Penny, Lunec, John

    Published in Cancers (20-12-2018)
    “…MAPK and p14 ⁻MDM2⁻p53 pathways are critical in cutaneous melanomas. Here, synergistic combination of the MEK inhibitor, trametinib, with MDM2 inhibitors,…”
    Get full text
    Journal Article
  2. 2

    TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response by Wu, Chiao-En, Koay, Tsin Shue, Ho, Yi-Hsuan, Lovat, Penny, Lunec, John

    Published in Cancer cell international (07-03-2019)
    “…Emergence of resistance to molecular targeted therapy constitutes a limitation to clinical benefits in cancer treatment. Cross-resistance commonly happens with…”
    Get full text
    Journal Article
  3. 3

    Abstract 3034: TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response by Wu, Chiao-En, Koay, Tsin Shue, Ho, Yi-Hsuan, Lovat, Penny, Lunec, John

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Emergence of resistance to molecular targeted therapy constitutes a potential limitation to clinical benefits in cancer treatment. Cross-resistance…”
    Get full text
    Journal Article
  4. 4
  5. 5